An Evaluation of an Algorithm for the Selection of Flexible Survival Models for Cancer Immunotherapies: Pass or Fail?
PharmacoEconomics · 2024
DOI: 10.1007/s40273-024-01429-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift PharmacoEconomics, 2024. Verfasst von Nicholas R Latimer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Delta Hat Limited, Bramley House, Bramley Road, Nottingham, NG10 3SX, UK. nlatimer@deltahat.com. Hauptthemen laut MEDLINE: Algorithms, Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Bristol-Myers Squibb.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Delta Hat Limited, Bramley House, Bramley Road, Nottingham, NG10 3SX, UK. nlatimer@deltahat.com.
- University of Sheffield, Sheffield, UK. nlatimer@deltahat.com.
- Delta Hat Limited, Bramley House, Bramley Road, Nottingham, NG10 3SX, UK.
- Department of Statistical Science, University College London, London, UK.
- Bristol Myers Squibb, Uxbridge, London, UK.
- Bristol Myers Squibb, Lawrenceville, NJ, USA.
ORCID-Profile: Nicholas R Latimer
Förderung
- Bristol-Myers Squibb
Zitieren
APA
Latimer, N. R., Taylor, K., Hatswell, A. J., Ho, S., Okorogheye, G., Chen, C., Kim, I., Borrill, J., & Bertwistle, D. (2024). An Evaluation of an Algorithm for the Selection of Flexible Survival Models for Cancer Immunotherapies: Pass or Fail?. PharmacoEconomics. https://doi.org/10.1007/s40273-024-01429-0
Vancouver
Latimer NR, Taylor K, Hatswell AJ, Ho S, Okorogheye G, Chen C, et al. An Evaluation of an Algorithm for the Selection of Flexible Survival Models for Cancer Immunotherapies: Pass or Fail?. PharmacoEconomics. 2024. doi:10.1007/s40273-024-01429-0
BibTeX
@article{Latimer2024,
author = {Latimer, Nicholas R and Taylor, Kurt and Hatswell, Anthony J and Ho, Sophia and Okorogheye, Gabriel and Chen, Clara and Kim, Inkyu and Borrill, John and Bertwistle, David},
title = {An Evaluation of an Algorithm for the Selection of Flexible Survival Models for Cancer Immunotherapies: Pass or Fail?},
journal = {PharmacoEconomics},
year = {2024},
doi = {10.1007/s40273-024-01429-0}
}
EUVIMED